Enveric Biosciences dismisses Marcum LLP, engages CBIZ CPAs as new auditor effective April 14

Enveric Biosciences, Inc.

Marcum LLP dismissed as independent auditor; CBIZ CPAs P.C. engaged effective April 14, 2025 for FY 2025.
Marcum's reports for FY 2024 and 2023 contained no adverse opinion, except a going concern paragraph for FY 2024.
No disagreements or reportable events between Enveric and Marcum during the relevant periods.
Material weaknesses in internal controls over financial reporting continue, as previously disclosed.
Change follows CBIZ CPAs' acquisition of Marcum's attest business on November 1, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.